Regeneron Stock – Regeneron Pharmaceuticals, Inc. (REGN) Stock price, News
Regeneron Stock – Regeneron Pharmaceuticals Inc. stock rises Wednesday, outperforms market
Shares of Regeneron Pharmaceuticals Inc.
REGN,
inched 0.65% higher to $481.79 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index
SPX,
rising 0.15% to 4,079.95 and the Dow Jones Industrial Average
DJIA,
rising 0.05% to 33,446.26. Regeneron Pharmaceuticals Inc. closed $182.85 below its 52-week high ($664.64), which the company reached on July 20th.
The stock outperformed some of its competitors Wednesday, as Johnson & Johnson
JNJ,
rose 0.13% to $163.61, Novartis AG ADR
NVS,
fell 0.07% to $86.30, and Amgen Inc.
AMGN,
fell 0.39% to $248.12. Trading volume (720,677) remained 309,703 below its 50-day average volume of 1.0 M.
Editor’s Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.
Regeneron Stock – Regeneron Pharmaceuticals Inc. stock rises Wednesday, outperforms market
Regeneron Stock – Regeneron Pharmaceuticals, Inc. (REGN) Stock price, News
Tags: Regeneron Stock, NASDAQ: REGN, Regeneron Pharmaceuticals
Stock Market, Latest News on C N N.
